Biotest

Biotest is a developer of plasma proteins and biopharmaceuticals, primarily focusing on clinical immunology, hematology, and intensive care medicine. The company’s industry chain has expanded from preclinical and clinical development to global sales. Its main products include immunoglobulins, coagulation factors, and albumin derived from human plasma. Additionally, Biotest has developed monoclonal antibodies for the treatment of plasma cell carcinoma and systemic lupus erythematosus.